Kardiomics Pty Ltd

Kardiomics is an Australian diagnostics company developing a qPCR test for the early detection of cardiovascular inflammation. The test targets SMuRF less patients, who present with first time heart attacks without standard risk factors, and supports monitoring of therapy effectiveness in patients with existing cardiovascular disease. Addressing a large global market, the test aims to fill a critical gap in cardiovascular risk detection and disease management.